Press Releases-SINOVAC: Supply Vaccines to Eliminate Human Diseases-page1

Company
Innovation
Products

News
Investors
Careers
- Our Talent
中文 EN
Contact Us

Company
News
Innovation
Products
Investors
Careers
- Our Talent
Contact Us

联系我们

当前地点：

EN

选择地点：

中文
EN

Home
Company
News
Innovation
Products
Investors
Careers
- Our Talent
Contact Us

中文
EN

Press Releases

ALL YEAR

All
YEAR 2024
YEAR 2023
YEAR 2022
YEAR 2021
YEAR 2020
YEAR 2019
YEAR 2018
YEAR 2017
YEAR 2016
YEAR 2015
YEAR 2014
YEAR 2013
YEAR 2012
YEAR 2011
YEAR 2010
YEAR 2009
YEAR 2008
YEAR 2007
YEAR 2006
YEAR 2005

2017/12/29

Sinovac Schedules 2017 Annual Meeting of Shareholders
2017/12/23

Sinovac Biotech Receives Positive Decision on its Hepatitis A Vaccine from World Health Organization
2017/12/01

Sinovac Biotech Cures Nasdaq Filing Deficiency
2017/12/01

Sinovac Reports Unaudited First Half of 2017 Financial Results
2017/11/30

Sinovac Biotech Announces Update on Nasdaq Matters
2017/11/23

Sinovac Files 2016 Annual Report on Form 20-F and Reports Unaudited Fourth Quarter 2016 Financial Results
2017/11/09

Sinovac Biotech Announces Request Hearing before Nasdaq Hearings Panel
2017/11/04

Sinovac Biotech Announces Receipt of DelistingDetermination Letter fromNasdaq
2017/09/25

Sinovac Reports Preliminary Top-Line Results from Phase III Clinical Trial for Varicella Vaccine Candidate Against Chickenpox
2017/08/14

Sinovac Biotech Announces Certain Updates Relating to Delayed Filing of Annual Report on Form 20-F
2017/06/26

Sinovac Biotech Ltd. Enters into Definitive Agreement for Going-Private Transaction
2017/05/17

Sinovac Biotech Announces Receipt of NASDAQ Letter
2017/05/01

Sinovac Reports Announces Filing Extension for 2016 Annual Report
2017/03/24

Sinovac Amends Shareholder Rights Plan

Previous page1Next page Go to No.

Follow Us

© SINOVAC All rights reserved